J&J Staves Off Generic Topamax
By Erin Coe · February 13, 2007, 12:00 AM EST
A federal judge has sided with a Johnson & Johnson company in a patent infringement case over Topamax, keeping Mylan Laboratories Inc.'s generic version of the epilepsy drug off the shelf....
To view the full article, register now.